Periodic Reporting for period 1 - NEUROSTAD (Characterization of the gene and protein networks regulated by Staufen 2 in neurogenesis and their alterations in AD)

Alzheimer's disease (AD) is a devastating neurodegenerative disorder affecting 60% of the 55 million people with dementia globally. It leads to a gradual loss of cognitive functions, posing a significant global health challenge. One critical aspect of AD is the impact on...